Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2012
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120315661 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
12/13/2012CA2835745A1 Pyridin - 2 - amides useful as cb2 agonists
12/12/2012EP2532665A1 Benzimidazole derivatives and pharmaceutical compositions and uses thereof
12/12/2012EP2532657A2 Compounds and methods of use
12/12/2012EP2531510A1 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
12/12/2012CN102822175A 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
12/12/2012CN102822165A Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/12/2012CN101631791B Substituted spirochromanone derivatives as ACC inhibitors
12/12/2012CN101486677B 5HT2C receptor modulators
12/11/2012US8329896 Spirooxazine radical derivatives and reversible isomerization reaction
12/11/2012US8329787 Weakly basic hindered amines compounds having carbonate skeletons, synthetic resin compositions and coating compositions
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329724 Process for the manufacture of pharmaceutically active compounds
12/11/2012US8329714 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
12/11/2012US8329701 Dihydrofuro pyrimidines as AKT protein kinase inhibitors
12/06/2012WO2012167171A2 Z-selective ring-closing metathesis reactions
12/06/2012WO2012162820A1 Maleimide-functionalized gold nanoparticles
12/06/2012WO2012162796A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
12/06/2012US20120309964 Cyclic amine compound and acaricide
12/06/2012US20120309823 Percutaneous absorption preparations
12/06/2012US20120309773 Heterocyclic compounds as janus kinase inhibitors
12/06/2012US20120309751 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
12/06/2012US20120309739 Akt / pkb inhibitors
12/06/2012US20120309717 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/06/2012CA2837359A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
12/05/2012EP2528922A1 Polyheterocyclic compounds highly potent as hcv inhibitors
12/05/2012EP2528910A1 5-alkynyl pyrimidines and their use as kinase inhibitors
12/05/2012EP2528900A1 Synthesis of substituted pyrazoline carboxamidine derivatives
12/05/2012EP2528440A1 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
12/05/2012CN102812005A Inhibitors of beta-secretase
12/05/2012CN101889010B Isoxazolo-pyridine derivatives
12/04/2012US8324262 Tricyclic necrostatin compounds
12/04/2012US8324239 Furopyridine compounds and uses thereof
12/04/2012US8324222 Cyclically substituted furopyrimidine derivatives and use thereof
12/04/2012US8323676 Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
12/04/2012CA2561313C Methods for minimizing thioamide impurities
11/2012
11/29/2012WO2012161877A1 Pyridine-and pyrazine derivatives
11/29/2012WO2012161119A1 Novel spiropiperidine derivative and pharmaceutical product containing same
11/29/2012US20120302761 Intermediates useful in the preparation of maleimide functionalized polymers
11/29/2012US20120302754 Production of alkaloids by liliaceae cell culture
11/29/2012US20120302747 Pyrrolotriazine kinase inhibitors
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302563 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
11/29/2012US20120302523 Endoperoxides and methods of photocatalytically synthesizing endoperoxides
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012CA2832605A1 Pyridine-and pyrazine derivatives
11/28/2012EP2526091A1 Derivatives of pyridoxine for inhibiting hiv integrase
11/28/2012CN1914509B Time-temperature indicator based on valence isomerizations
11/28/2012CN102803268A Histamine H3 inverse agonists and antagonists and methods of use thereof
11/28/2012CN102803236A Synthesis of TTX intermediates
11/28/2012CN102803228A Acid-labile trigger units
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102796111A Carboxylate (sulfonate) compounds with oxoaza-spiro-amido group, and preparation method and application thereof
11/28/2012CN102796110A Aniline pyrimidine compound and preparation method and application thereof
11/28/2012CN102796109A 4-aminoquinazoline compound and preparation method and application thereof
11/28/2012CN102796096A Hexahydro dibenzo [a,g] quinolizidine compound and preparation method, medicinal composition and application thereof
11/28/2012CN102796086A Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/28/2012CN102150670B Application of phenanthroindolizidine and phenanthroquinolizidine derivatives and salts thereof in pesticides
11/28/2012CN101993446B Novel benzanthracene cyclic compounds and preparation method and use thereof
11/28/2012CN101855224B Equilibrative nucleoside transporter ENT1 inhibitors
11/28/2012CN101258130B Isoquinolines as igf-1r inhibitors
11/27/2012US8318928 Fused imidazole carboxamides as TRPV3 modulators
11/27/2012US8318762 Pyrazolospiroketone acetyl-CoA carboxylase inhibitors
11/27/2012US8318753 (-)-5-(3-Chlorophenyl)- alpha -(4-chlorophenyl)- alpha -(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts; anticancer agent
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318502 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
11/27/2012CA2643400C Camptothecin derivatives and their uses
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012156677A1 A stable micronised monoclinic form of asenapine maleate and its synthesis
11/22/2012WO2012156676A1 Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
11/22/2012WO2012156384A1 Novel crystalline salts of asenapine
11/22/2012WO2012156383A1 Novel crystalline salts of asenapine with organic di-acids and tri-acids
11/22/2012WO2012156382A1 Novel crystalline asenapine hydrochloride salt forms
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295882 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/22/2012US20120295318 Cyclopropenones and the photochemical generation of cyclic alkynes therefrom
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/21/2012EP2524921A1 Novel Crystalline Salts of Asenapine
11/21/2012EP2524920A1 Novel Crystalline Asenapine Hydrochloride Salt Forms
11/21/2012EP2524919A1 Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
11/21/2012CN1850824B Benzene-free tetrandrine and preparing method thereof
11/21/2012CN102791715A Tricyclic compounds for use as kinase inhibitors
11/21/2012CN102786604A Method for one-time separation and extraction of dendrobe polysaccharide, dendrobine and erianin from dendrobium candidum
11/21/2012CN102786528A Polyoxybiotic alkali compound as well as preparation method and application thereof
11/21/2012CN102786508A Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102060991B Amphiphilic prodrug of 7- ethyl-10-hydroxycamptothecin and preparation method thereof
11/21/2012CN101003556B Derivative of 10 - hydroxyl camptothecin, prepartion of liposome thereof, and preparation method
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012CA2611530C Tyrosine kinase inhibitors
11/20/2012CA2537559C Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/15/2012WO2012154676A1 Partially saturated tricyclic compounds and methods of making and using same
11/15/2012US20120289702 Nitrogen-containing heterocyclic compound and agricultural fungicide
11/15/2012US20120289535 Dual phase drug release system
11/15/2012US20120289525 Pyrimidine ether derivatives and methods of use thereof
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 298